作者
Thomas Lindner,Divya S. Bolar,Eric Achten,Frederik Barkhof,António J. Bastos‐Leite,John A. Detre,Xavier Golay,Matthias Günther,Danny J.J. Wang,Sven Haller,Silvia Ingala,Hans Rolf Jäger,Geon‐Ho Jahng,Meher R. Juttukonda,Vera C. Keil,Hirohiko Kimura,Mai‐Lan Ho,Maarten H. Lequin,Xin Lou,Jan Petr,Nándor Pintér,Francesca B. Pizzini,Marion Smits,Magdalena Sokolska,Greg Zaharchuk,Henk J. M. M. Mutsaerts
摘要
This article focuses on clinical applications of arterial spin labeling (ASL) and is part of a wider effort from the International Society for Magnetic Resonance in Medicine (ISMRM) Perfusion Study Group to update and expand on the recommendations provided in the 2015 ASL consensus paper. Although the 2015 consensus paper provided general guidelines for clinical applications of ASL MRI, there was a lack of guidance on disease‐specific parameters. Since that time, the clinical availability and clinical demand for ASL MRI has increased. This position paper provides guidance on using ASL in specific clinical scenarios, including acute ischemic stroke and steno‐occlusive disease, arteriovenous malformations and fistulas, brain tumors, neurodegenerative disease, seizures/epilepsy, and pediatric neuroradiology applications, focusing on disease‐specific considerations for sequence optimization and interpretation. We present several neuroradiological applications in which ASL provides unique information essential for making the diagnosis. This guidance is intended for anyone interested in using ASL in a routine clinical setting (i.e., on a single‐subject basis rather than in cohort studies) building on the previous ASL consensus review.